Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02775045 · ClinicalTrials.gov registry record
Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 28
- Enrollment target
NCT02775045 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 28 participants.
The verdict
NCT02775045 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to improve the overall management of patients with Eosinophil Esophagitis. Currently, the best way to monitor Eosinophil Esophagitis is repeating the endoscopy procedure. The investigators plan to identify a biomarker in the blood (a measurable substance) that tracks with disease activity and will reduce the need for follow-up endoscopies.
Interventions
- OTHER Observation Period
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2016-08-30 |
| Est. Completion | 2018-12-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02775045
The ClinicalTrials.gov registry entry for NCT02775045 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observation Period is the first listed.
NCT02775045 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02775045 about?
NCT02775045 is a clinical study titled "Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis". The purpose of this study is to improve the overall management of patients with Eosinophil Esophagitis. Currently, the best way to monitor Eosinophil Esophagitis is repeating the endoscopy procedure. The investigators plan to identify a biomarker in the blood (a measurable substance) that tracks wit...
What is the current status of trial NCT02775045?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2016-08-30. Estimated completion is 2018-12-13.
What interventions are being tested in trial NCT02775045?
The interventions under investigation include: Observation Period (OTHER).
Who is sponsoring clinical trial NCT02775045?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.